替勃龙、阿仑膦酸钠和辛伐他汀增强临床前模型种植体骨整合
微型CT显示替勃龙组骨组织显著高于去卵巢组,但治疗组间无显著差异;替勃龙拉出测试值最高,阿仑膦酸钠结果更一致。结论认为三种药物均增强骨整合,替勃龙可能效果最佳。
要点
- 替勃龙组种植体周围骨组织显著高于去卵巢组。
- 替勃龙拉出测试值最高,阿仑膦酸钠结果更一致。
- 三种药物均增强去卵巢大鼠钛种植体骨整合。
核心结论
- 阿仑膦酸钠、辛伐他汀和替勃龙均增强去卵巢大鼠钛种植体骨整合,替勃龙可能效果最佳。
研究设计与样本
- 去卵巢后3个月行双侧钛髓内钉植入,随后口服相应药物12周,检测微型CT、机械拉出测试、组织学和骨血清标志物。
主要发现
- 微型CT显示替勃龙组种植体周围总体骨组织显著高于去卵巢组,治疗组间无显著差异。
- 假去卵巢组、阿仑膦酸钠组和替勃龙组体质量密度高于去卵巢组和辛伐他汀组。
- 所有治疗组种植体周围密质骨层厚度大于去卵巢组,但差异无统计学意义。
- 替勃龙组拉出测试值最高,阿仑膦酸钠组结果更一致地阳性。
- 替勃龙组骨钙素值约为去卵巢组三倍,但差异无统计学意义。
临床怎么用
- 动物实验提示替勃龙、阿仑膦酸钠和辛伐他汀可能促进种植体骨整合,但尚未在人体验证。
局限性
- 研究为去卵巢大鼠临床前模型,结果不能直接外推至人类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of the study was to evaluate and compare the effect of different drugs such as simvastatin, alendronate, and tibolone for titanium implant osseointegration enhancement. MATERIALS AND METHODS: Eighty female albino Wistar rats were equally divided into five groups: Group I (ovariectomy), Group II (sham ovariectomy), Group III (alendronate + ovariectomy), Group IV (simvastatin + ovariectomy), and Group V (tibolone + ovariectomy). Three months after ovariectomy, we performed bilateral titanium intramedullary nailing in all groups, followed by oral administration of alendronate, simvastatin, or tibolone for 12 weeks. Examinations included micro-CT, mechanical pull-out test, histology, and bone serum markers. RESULTS: Peri-implant micro-CT analysis showed a significantly higher overall bone tissue in tibolone compared to the ovariectomy group, while no significant difference was found between the treatment groups. Sham ovariectomy, alendronate, and tibolone groups had a higher body mass density compared to ovariectomy and simvastatin groups. All treatment groups had a greater thickness of the peri-implant compact bone layer compared to ovariectomy group, but the results were not statistically significant. Tibolone presented the highest values in pull-out test, but alendronate showed more consistently positive results compared to other groups. Osteocalcin had in the tibolone group almost three times the value in the ovariectomy group, but the results were not statistically significant. CONCLUSION: The hypothesis that alendronate, simvastatin, and tibolone enhance the osseointegration process of intramedullary titanium implants in ovariectomized rats has been accepted, while tibolone could offer the best results.
引用
- Apostu D, Lucaciu O, Mester A, et al. Tibolone, alendronate, and simvastatin enhance implant osseointegration in a preclinical in vivo model. Clin Oral Implants Res. 2020. PMID: 32279374. doi:10.1111/clr.13602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。